Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
334 studies found for:    Open Studies | "Sarcoma"
Show Display Options
Rank Status Study
21 Not yet recruiting Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery
Condition: Sarcoma
Interventions: Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
22 Recruiting NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy
Condition: Sarcoma
Interventions: Biological: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes;   Other: Laboratory Biomarker Analysis;   Radiation: Palliative Radiation Therapy
23 Recruiting MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study
Condition: Sarcoma
Intervention: Device: MRI scanning
24 Recruiting Study in Localized and Disseminated Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Zoledronic acid;   Drug: Busulfan;   Drug: Treosulfan
25 Recruiting Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide
Condition: Soft-tissue Sarcomas
Interventions: Drug: Phase 1: Trabectedin;   Drug: Phase 2: Trabectedin;   Drug: Phase 1: Cyclophosphamide;   Drug: Phase 2: Cyclophosphamide
26 Recruiting Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Doxorubicin;   Drug: Ifosfamide;   Radiation: radiotherapy
27 Recruiting Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX
28 Recruiting Pomalidomide for Kaposi Sarcoma in People With or Without HIV
Conditions: Kaposi Sarcoma;   Sarcoma, Kaposi
Intervention: Drug: Pomalidomide
29 Recruiting Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Condition: Sarcoma, Kaposi
Interventions: Drug: Liposomal Doxorubicin;   Drug: Bevacizumab
30 Recruiting Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma
Condition: Sarcoma, Soft-tissue
Intervention: Drug: pazopanib
31 Recruiting A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
Condition: Synovial Sarcoma
Intervention: Biological: NY-ESO-1(c259)T Cells
32 Recruiting IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
Condition: Uterine Sarcoma
Interventions: Drug: Cabozantinib;   Drug: Placebo
33 Recruiting Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients
Conditions: Sarcoma;   Soft Tissue Sarcomas
Interventions: Radiation: external beam radiotherapy;   Drug: pazopanib
34 Recruiting Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)
Condition: Retroperitoneal Soft Tissue Sarcoma
Interventions: Radiation: Neoadjuvant intensity-modulated radiation therapy (IMRT);   Radiation: intraoperative radiation therapy (IORT)
35 Recruiting DHEA in Synovial Sarcoma Patients
Conditions: Synovial Sarcoma;   Sarcoma, Synovial
Interventions: Drug: DHEA;   Other: FACT-67 validated survey
36 Recruiting Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: Olaparib;   Drug: Temozolomide;   Drug: Irinotecan
37 Recruiting Stereotactic Radiosurgery for Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Radiation: CyberKnife
38 Recruiting Proton or Photon RT for Retroperitoneal Sarcomas
Condition: Retroperitoneal Sarcoma
Interventions: Radiation: IG-IMPT;   Radiation: IG IMRT
39 Recruiting Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Conditions: Alveolar Soft Part Sarcoma;   Soft Tissue Sarcomas
Interventions: Drug: Axitinib;   Drug: Pembrolizumab;   Procedure: Blood Draw;   Procedure: Tumor Specimen Collection
40 Recruiting Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Condition: Sarcoma, Alveolar Soft Part
Intervention: Drug: AZD2171

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.